David Rodman
Vermogen: 2 M $ op 31-05-2026
Vermogen: 2 M $ op 31-05-2026
David M.
Rodman is currently a Member-Editorial Board at American Thoracic Society, Inc. and Chief Medical Officer at Mineralys Therapeutics, Inc. since 2021.
Former roles include Vice President-Clinical Development at Vertex Pharmaceuticals, Inc. from 2011 to 2014; Executive Vice President-Research & Development at miRagen Therapeutics, Inc.; Professor at The University of Colorado; Head-Respiratory Translational Medicine at Novartis Institutes for Biomedical Research, Inc.; Chief Medical Officer & Executive VP-Discovery at Nivalis Therapeutics, Inc. from 2016 to 2017; and Executive Vice President-Research & Development at ProQR Therapeutics NV.
Education includes a doctorate from the University of Pennsylvania in 1980 and an undergraduate degree from Haverford College in 1976.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 17-06-2026 | 57.095 ( 0,08% ) | 2 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| MINERALYS THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2021 |
American Thoracic Society, Inc.
American Thoracic Society, Inc. Miscellaneous Commercial ServicesCommercial Services Profession membership organization for thoracic surgeons. | Corporate Officer/Principal | - |
| Bedrijven | Functie | Einde |
|---|---|---|
Nivalis Therapeutics, Inc.
Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of products for patients with cystic fibrosis | Hoofd Techniek/Wetenschap/O&O | 15-01-2017 |
| VERTEX PHARMACEUTICALS INCORPORATED | Hoofd Techniek/Wetenschap/O&O | 01-04-2014 |
| PROQR THERAPEUTICS N.V. | Hoofd Techniek/Wetenschap/O&O | - |
The University of Colorado
The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 10 |
|---|---|
Vertex Pharmaceuticals, Inc.
Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
miRagen Therapeutics, Inc. /Old/
miRagen Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops microRNA-based therapeutics for cardiovascular and muscle diseases | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Haverford College
Haverford College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Colorado
The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Commercial Services |
American Thoracic Society, Inc.
American Thoracic Society, Inc. Miscellaneous Commercial ServicesCommercial Services Profession membership organization for thoracic surgeons. | Commercial Services |
Nivalis Therapeutics, Inc.
Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of products for patients with cystic fibrosis | Health Technology |
ProQR Therapeutics NV
ProQR Therapeutics NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company with interest in the discovery and development of therapeutics for the treatment of genetic disorders | Health Technology |
Mineralys Therapeutics, Inc.
Mineralys Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops medicines to target diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau